236 related articles for article (PubMed ID: 22294228)
1. Fear-potentiated startle and light-enhanced startle models in drug discovery.
Groenink L; Bijlsma EY; Olivier B
Curr Protoc Pharmacol; 2008 Jun; Chapter 5():Unit5.48. PubMed ID: 22294228
[TBL] [Abstract][Full Text] [Related]
2. Favoured genetic background for testing anxiolytics in the fear-potentiated and light-enhanced startle paradigms in the rat.
Steiner MA; Lecourt H; Rakotoariniaina A; Jenck F
Behav Brain Res; 2011 Aug; 221(1):34-42. PubMed ID: 21354212
[TBL] [Abstract][Full Text] [Related]
3. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats.
Li X; Kaczanowska K; Finn MG; Markou A; Risbrough VB
Neuropharmacology; 2015 Oct; 97():357-64. PubMed ID: 26002628
[TBL] [Abstract][Full Text] [Related]
4. Light-enhanced and fear-potentiated startle: temporal characteristics and effects of alpha-helical corticotropin-releasing hormone.
de Jongh R; Groenink L; van der Gugten J; Olivier B
Biol Psychiatry; 2003 Nov; 54(10):1041-8. PubMed ID: 14625146
[TBL] [Abstract][Full Text] [Related]
5. The contribution of contextual fear in the anxiolytic effect of chlordiazepoxide in the fear-potentiated startle test.
Zhao Y; Bijlsma EY; Verdouw PM; Garssen J; Groenink L
Behav Brain Res; 2018 Nov; 353():57-61. PubMed ID: 29969605
[TBL] [Abstract][Full Text] [Related]
6. Fear-potentiated startle in rats.
Davis M
Curr Protoc Neurosci; 2001 May; Chapter 8():Unit 8.11A. PubMed ID: 18428539
[TBL] [Abstract][Full Text] [Related]
7. Fear-potentiated startle, but not light-enhanced startle, is enhanced by anxiogenic drugs.
Bijlsma EY; de Jongh R; Olivier B; Groenink L
Pharmacol Biochem Behav; 2010 Jul; 96(1):24-31. PubMed ID: 20394767
[TBL] [Abstract][Full Text] [Related]
8. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle.
Grillon C; Baas JM; Pine DS; Lissek S; Lawley M; Ellis V; Levine J
Biol Psychiatry; 2006 Oct; 60(7):760-6. PubMed ID: 16631127
[TBL] [Abstract][Full Text] [Related]
9. Effects of oxytocin on background anxiety in rats with high or low baseline startle.
Ayers L; Agostini A; Schulkin J; Rosen JB
Psychopharmacology (Berl); 2016 Jun; 233(11):2165-2172. PubMed ID: 27004789
[TBL] [Abstract][Full Text] [Related]
10. Anxiogenic treatments do not increase fear-potentiated startle in mice.
Risbrough VB; Geyer MA
Biol Psychiatry; 2005 Jan; 57(1):33-43. PubMed ID: 15607298
[TBL] [Abstract][Full Text] [Related]
11. Benzodiazepines have no effect on fear-potentiated startle in humans.
Baas JM; Grillon C; Böcker KB; Brack AA; Morgan CA; Kenemans JL; Verbaten MN
Psychopharmacology (Berl); 2002 May; 161(3):233-47. PubMed ID: 12021826
[TBL] [Abstract][Full Text] [Related]
12. Oxytocin reduces background anxiety in a fear-potentiated startle paradigm.
Missig G; Ayers LW; Schulkin J; Rosen JB
Neuropsychopharmacology; 2010 Dec; 35(13):2607-16. PubMed ID: 20844476
[TBL] [Abstract][Full Text] [Related]
13. Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.
Baas JM; Mol N; Kenemans JL; Prinssen EP; Niklson I; Xia-Chen C; Broeyer F; van Gerven J
Psychopharmacology (Berl); 2009 Jul; 205(1):73-84. PubMed ID: 19415242
[TBL] [Abstract][Full Text] [Related]
14. The effects of sex and neonatal maternal separation on fear-potentiated and light-enhanced startle.
de Jongh R; Geyer MA; Olivier B; Groenink L
Behav Brain Res; 2005 Jun; 161(2):190-6. PubMed ID: 15878207
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man.
Bitsios P; Philpott A; Langley RW; Bradshaw CM; Szabadi E
J Psychopharmacol; 1999; 13(3):226-34. PubMed ID: 10512076
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and pharmacological validation of an integrated fear-potentiated startle and prepulse inhibition paradigm.
Zhang M; Li M
Behav Brain Res; 2016 Jul; 307():176-85. PubMed ID: 27059335
[TBL] [Abstract][Full Text] [Related]
17. Cocaine preexposure sensitizes conditioned fear in a potentiated acoustic startle paradigm.
Borowski TB; Kokkinidis L
Pharmacol Biochem Behav; 1994 Dec; 49(4):935-42. PubMed ID: 7886110
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic effects of buspirone and gepirone in the fear-potentiated startle paradigm.
Kehne JH; Cassella JV; Davis M
Psychopharmacology (Berl); 1988; 94(1):8-13. PubMed ID: 2894703
[TBL] [Abstract][Full Text] [Related]
19. Contextual fear conditioning and baseline startle responses in the rat fear-potentiated startle test: a comparison of benzodiazepine/gamma-aminobutyric acid-A receptor agonists.
Guscott MR; Cook GP; Bristow LJ
Behav Pharmacol; 2000 Sep; 11(6):495-504. PubMed ID: 11103915
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effects of the neurokinin 1 receptor antagonist GR-205171 in the elevated plus maze and contextual fear-potentiated startle model of anxiety in gerbils.
Heldt SA; Davis M; Ratti E; Corsi M; Trist D; Ressler KJ
Behav Pharmacol; 2009 Oct; 20(7):584-95. PubMed ID: 19675456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
